| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| DANIEL DOLLINGER CPA | 2,100 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| PROSPECT CAPITAL CO | 2016-07 | PURCHASE | 2018-12 | 28,950 | 40,142 | -11,192 | ||||
| PROSPECT CAPITAL CO | 2015-06 | PURCHASE | 2018-12 | 27,213 | 36,574 | -9,361 | ||||
| PROSPECT CAPITAL CO | 2015-06 | PURCHASE | 2018-12 | 1,737 | 2,335 | -598 | ||||
| PROSPECT CAPITAL CO | 2016-07 | PURCHASE | 2018-12 | 28,950 | 41,592 | -12,642 | ||||
| PROSPECT CAPITAL CO | 2015-10 | PURCHASE | 2018-12 | 1,158 | 1,444 | -286 | ||||
| PROSPECT CAPITAL CO | 2015-10 | PURCHASE | 2018-12 | 27,792 | 34,712 | -6,920 | ||||
| HERCULES CAPITAL INC | 2010-10 | PURCHASE | 2018-12 | 1,068 | 1,034 | 34 | ||||
| HERCULES CAPITAL INC | 2012-11 | PURCHASE | 2018-12 | 4,272 | 4,252 | 20 | ||||
| NEW YORK CMNTY BANCO | 2012-11 | PURCHASE | 2018-12 | 1,787 | 2,538 | -751 | ||||
| HERCULES CAPITAL INC | 2010-02 | PURCHASE | 2018-12 | 10,681 | 9,500 | 1,181 | ||||
| HERCULES CAPITAL INC | 2012-02 | PURCHASE | 2018-12 | 8,545 | 8,400 | 145 | ||||
| HERCULES CAPITAL INC | 2010-04 | PURCHASE | 2018-12 | 2,136 | 2,234 | -98 | ||||
| UBS ETRACS MONTH PAY 2XL EV CEF ETN | 2016-07 | PURCHASE | 2018-12 | 21,920 | 36,322 | -14,402 | ||||
| UBS ETRACS MONTH PAY 2XL EV CEF ETN | 2016-07 | PURCHASE | 2018-12 | 3,288 | 5,453 | -2,165 | ||||
| UBS ETRACS MONTH PAY 2XLEV CEF ETN | 2016-07 | PURCHASE | 2018-12 | 230 | 382 | -152 | ||||
| PEMBINA PIPELINE CO F | 2018-06 | PURCHASE | 2018-12 | 91,559 | 104,270 | -12,711 | ||||
| UBS ETRACS MONTH PAY 2XL EV CEF ETN | 2016-07 | PURCHASE | 2018-12 | 3,288 | 5,452 | -2,164 | ||||
| UBS ETRACS MONTH PAY 2XL EV CEF ETN | 2016-07 | PURCHASE | 2018-12 | 21,920 | 36,347 | -14,427 | ||||
| UBS ETRACS MONTH PAY 2XL EV CEF ETN | 2016-07 | PURCHASE | 2018-12 | 252 | 418 | -166 | ||||
| UBS ETRACS MONTH PAY 2XLEV CEF ETN | 2016-07 | PURCHASE | 2018-12 | 3,288 | 5,219 | -1,931 | ||||
| UBS ETRACS MONTH PAY 2XLEV CEF ETN | 2016-07 | PURCHASE | 2018-12 | 2,192 | 3,479 | -1,287 | ||||
| UBS ETRACS MONTH PAY 2XL EV CEF ETN | 2016-07 | PURCHASE | 2018-12 | 1,962 | 3,254 | -1,292 | ||||
| UBS ETRACS MONTH PAY 2XLEV CEF ETN | 2016-07 | PURCHASE | 2018-12 | 1,940 | 3,216 | -1,276 | ||||
| UBS ETRACS MONTH PAY 2XL EV CEF ETN | 2016-07 | PURCHASE | 2018-12 | 5,480 | 8,698 | -3,218 | ||||
| A T & T INC | 2017-11 | PURCHASE | 2018-12 | 171,194 | 209,902 | -38,708 | ||||
| ABBVIE INC | 2018-03 | PURCHASE | 2018-12 | 169,259 | 196,718 | -27,459 | ||||
| NEW YORK CMNTY BANCO | 2012-11 | PURCHASE | 2018-12 | 2,009 | 2,855 | -846 | ||||
| BRIT AMER TOBACCO F SPON SORED ADR 1 | 2017-07 | PURCHASE | 2018-12 | 33,453 | 72,851 | -39,398 | ||||
| BRIT AMER TOBACCO F SPON SORED ADR 1 | 2017-10 | PURCHASE | 2018-12 | 12,720 | 25,614 | -12,894 | ||||
| BRIT AMER TOBACCO F SPONSORED ADR 1 | 2017-10 | PURCHASE | 2018-12 | 17,426 | 35,091 | -17,665 | ||||
| NEW YORK CMNTY BANCO | 2012-11 | PURCHASE | 2018-12 | 24,780 | 35,215 | -10,435 | ||||
| NEW YORK CMNTY BANCO | 2013-07 | PURCHASE | 2018-12 | 12,502 | 20,743 | -8,241 | ||||
| NEW YORK CMNTY BANCO | 2017-06 | PURCHASE | 2018-12 | 17,860 | 25,325 | -7,465 | ||||
| NEW YORK CMNTY BANCO | 2012-11 | PURCHASE | 2018-12 | 3,573 | 5,076 | -1,503 | ||||
| NEW YORK CMNTY BANCO | 2017-10 | PURCHASE | 2018-12 | 17,860 | 25,603 | -7,743 | ||||
| NEW YORK CMNTY BANCO | 2017-01 | PURCHASE | 2018-12 | 26,790 | 45,299 | -18,509 | ||||
| MOMENTA PHARMACEUTIC | 2015-11 | PURCHASE | 2018-03 | 33,119 | 30,584 | 2,535 | ||||
| RETROPHIN INC | 2014-05 | PURCHASE | 2018-03 | 9,606 | 5,435 | 4,171 | ||||
| MOMENTA PHARMACEUTIC | 2016-07 | PURCHASE | 2018-03 | 3,320 | 2,233 | 1,087 | ||||
| MOMENTA PHARMACEUTIC | 2015-11 | PURCHASE | 2018-03 | 4,971 | 4,588 | 383 | ||||
| MOMENTA PHARMACEUTIC | 2015-11 | PURCHASE | 2018-03 | 4,966 | 4,588 | 378 | ||||
| RETROPHIN INC | 2014-05 | PURCHASE | 2018-03 | 9,807 | 5,548 | 4,259 | ||||
| MOMENTA PHARMACEUTIC | 2015-11 | PURCHASE | 2018-03 | 28,172 | 25,996 | 2,176 | ||||
| MOMENTA PHARMACEUTIC | 2015-11 | PURCHASE | 2018-03 | 28,143 | 26,370 | 1,773 | ||||
| RETROPHIN INC | 2014-04 | PURCHASE | 2018-03 | 11,125 | 5,802 | 5,323 | ||||
| RETROPHIN INC | 2014-04 | PURCHASE | 2018-03 | 3,358 | 1,752 | 1,606 | ||||
| RETROPHIN INC | 2014-04 | PURCHASE | 2018-03 | 445 | 232 | 213 | ||||
| MOMENTA PHARMACEUTIC | 2016-07 | PURCHASE | 2018-03 | 6,640 | 4,466 | 2,174 | ||||
| MOMENTA PHARMACEUTIC | 2015-11 | PURCHASE | 2018-03 | 11,620 | 10,704 | 916 | ||||
| MOMENTA PHARMACEUTIC | 2016-07 | PURCHASE | 2018-03 | 11,620 | 7,816 | 3,804 | ||||
| RETROPHIN INC | 2014-05 | PURCHASE | 2018-03 | 2,234 | 1,264 | 970 | ||||
| RETROPHIN INC | 2014-05 | PURCHASE | 2018-03 | 693 | 392 | 301 | ||||
| RETROPHIN INC | 2014-04 | PURCHASE | 2018-03 | 2,091 | 1,091 | 1,000 | ||||
| RETROPHIN INC | 2014-04 | PURCHASE | 2018-03 | 5,224 | 2,727 | 2,497 | ||||
| BIOMARIN PHARMACEUTL | 2012-03 | PURCHASE | 2018-03 | 25,259 | 10,138 | 15,121 | ||||
| MOMENTA PHARMACEUTIC | 2015-11 | PURCHASE | 2018-03 | 6,354 | 5,429 | 925 | ||||
| BIOMARIN PHARMACEUTL | 2012-11 | PURCHASE | 2018-03 | 101,038 | 57,888 | 43,150 | ||||
| MOMENTA PHARMACEUTIC | 2015-11 | PURCHASE | 2018-03 | 29,947 | 25,594 | 4,353 | ||||
| MOMENTA PHARMACEUTIC | 2015-11 | PURCHASE | 2018-03 | 18,205 | 15,512 | 2,693 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| CHARLES SCHWAB | 2,335,952 | 3,242,038 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| ALEXANDRIA REAL | AT COST | 221,881 | 288,100 |
| E-TRACKS | AT COST | ||
| WEYERHAEUSER REIT | AT COST | 262,416 | 209,856 |
| GLOBAL PARTNERS LP | AT COST | 111,550 | 130,400 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| DUNN CORNEY | 500 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| ADR FEES | 295 | 295 | ||
| FEDERAL TAXES | 165 | |||
| OTHER | -7,133 | -7,133 | ||
| STORAGE COSTS | 2,400 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| OUTSTANDING CHECKS | 42,500 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| MILHALKO | 1,260 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| CORPORATION DIVISION | 50 | |||
| DEPARTMENT OF JUSTICE | 613 | |||
| FOREIGN TAX | 650 | 650 |